Early Outcomes of Redo-TAVI With SAPIEN Platform in a Real-World Prospective Cohort: The ReTAVI Registry

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>lecture fees <10K - Abbott; Abiomed; Boston Scientific Corporation; Edwards Lifesciences; Medtronic; Microport</li></ul>